Back
Keros Therapeutics Stock Predictions
Sponsored
KROS
Sponsored
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!
Buy
62
KROS
Keros Therapeutics
Last Price:
56.44
Seasonality Move:
54.08%
7 Day Trial
ALL ACCESS PASS
$
7
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Keros Therapeutics Stock Forecast
- Over the next 52 weeks, Keros Therapeutics has on average historically risen by 11.5% based on the past 4 years of stock performance.
- Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Keros Therapeutics Stock Undervalued?
The current Keros Therapeutics [KROS] share price is $56.45. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal. - KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Keros Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Keros Therapeutics has on average historically risen by 11.5% based on the past 4 years of stock performance.
Keros Therapeutics Stock Rating
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics overpriced?
- Keros Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Keros Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com
52-Week Data
52-Week High:
73.00
52-Week Low:
27.02
Prediction Charts
Market Cap:
2.12B
Price in USD:
56.45
Volume:
283.46K
Beta:
1.12
Technical Analysis
SMA50:
50.20
SMA100:
49.38
SMA200:
52.84
52-Wk Change:
76.19%
Stock Predictions
-
Is Keros Therapeutics stock public?
Yes, Keros Therapeutics is a publicly traded company. -
What is the Keros Therapeutics stock quote today?
The Keros Therapeutics stock price is 56.45 USD today. -
How to buy Keros Therapeutics stock online?
You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Sep-10 | 54.08 | 54.69 | 55.25 | 53.45 |
Sep-11 | 54.59 | 54.75 | 55.20 | 53.60 |
Sep-12 | 54.50 | 56.40 | 56.48 | 54.07 |
Sep-13 | 56.94 | 56.98 | 58.36 | 55.89 |
Sep-16 | 57.09 | 55.62 | 57.77 | 55.21 |
Sep-17 | 55.68 | 55.04 | 55.72 | 54.60 |
Sep-18 | 55.04 | 55.71 | 57.08 | 54.44 |
Sep-19 | 57.21 | 57.32 | 58.28 | 56.30 |
Sep-20 | 57.28 | 55.80 | 57.77 | 55.79 |
Sep-23 | 58.15 | 54.54 | 58.31 | 54.11 |
Sep-24 | 54.76 | 55.59 | 55.79 | 53.65 |
Sep-25 | 55.66 | 56.45 | 57.49 | 55.06 |
Sep-26 | 56.94 | 56.92 | 59.06 | 56.34 |
Sep-27 | 57.31 | 56.45 | 58.19 | 55.93 |
Keros Therapeutics Earnings
Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Keros Therapeutics Forecast Revenue Growth
Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.02 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.